Navigation Links
PROLOR Biotech Announces Initiation of Phase I Clinical Trial for its Long-Acting Growth Hormone
Date:9/21/2009

logy could also be affected by a number of other factors, including unexpected safety, efficacy or manufacturing issues, additional time requirements for data analyses and decision making, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing and the impact of patents and other proprietary rights held by competitors and other third parties. In addition to the risk factors described above, investors should consider the economic, competitive, governmental, technological and other factors discussed in PROLOR's filings with the Securities and Exchange Commission.

    PROLOR CONTACT:                      MEDIA CONTACT:
    Shai Novik, President                Barbara Lindheim
    PROLOR Biotech, Inc.                 GendeLLindheim BioCom Partners
    Tel: +1 866 644-7811                 +1 212 918-4650
    Email: shai@prolor-biotech.com       blindheim@biocompartners.com


'/>"/>
SOURCE PROLOR Biotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin
2. PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
3. PROLOR Biotech Acquires License Option from Yeda for Development of Long-Acting Anti-Obesity Drug
4. PROLOR Biotech to Present at the UBS 2009 Global Life Sciences Conference
5. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
8. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
9. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
10. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
11. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... GLEN BURNIE, Md. , Aug. 19, 2014 /PRNewswire/ ... the clinical research industry, recently announced the formation of ... is pleased to announce the addition of Dr. ... Photo - http://photos.prnewswire.com/prnh/20140818/136957 ... insight across a variety of therapeutic areas and set ...
(Date:8/19/2014)... 19, 2014   Synthetic Biologics, Inc. ... anti-infective biologic and drug programs targeting specific pathogens ... that its novel C. difficile development ... Interscience Conference on Antimicrobial Agents and Chemotherapy ... Synthetic Biologics, Senior Vice ...
(Date:8/19/2014)... (PRWEB) August 19, 2014 Sales Horizons, ... of its online sales skills training course ... skills. , MedTech clinical staff spend the majority of ... hospital, standalone medical center, or physician practice – providing ... But why stop there? Sales Horizons believes clinical staff ...
(Date:8/18/2014)... FL (Aug. 18, 2014) -- A new therapy ... Florida (USF) Morsani College of Medicine and Columbia ... life-threatening complications of interventional cardiovascular disease treatment. ... that the novel molecular therapy could selectively inhibit ... following a medical procedure using a balloon catheter ...
Breaking Biology Technology:CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 2CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 4Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 2Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 3Selective therapy may improve artery repair after interventional cardiovascular procedures 2Selective therapy may improve artery repair after interventional cardiovascular procedures 3
... THE WOODLANDS, Texas, June 2 Lexicon Pharmaceuticals, ... the appointment of Ajay Bansal as executive vice president, corporate ... than 20 years of experience in the biotechnology and pharmaceutical ... and commercial operations. , , Prior to ...
... ... 100% digital hearing aid that does not require a prescription. , ... (PRWEB) June 2, 2009 -- For many people, hearing ... to visit a doctor. An estimated 10% of Americans suffer from hearing loss to ...
... Va. The American Institute of Aeronautics and ... of top emerging aerospace technologies. Developed by ... the following: 1. "Greener Aviation" Technologies including ... in the Federal Aviation Administration,s Continuous Low Emissions, ...
Cached Biology Technology:Lexicon Names Ajay Bansal Executive Vice President and Chief Financial Officer 2Lexicon Names Ajay Bansal Executive Vice President and Chief Financial Officer 3Prescription-Free Digital Hearing Aid Just Released 2AIAA names top ten emerging aerospace technologies of 2009 2
(Date:8/18/2014)... 19, 2014 ,Trustonic ... in smart devices  Trustonic, the leading ... devices, and Fingerprint Cards AB (FPC) today announced ... Ready™ secure biometric authentication on connected devices. ... sensors (FPC1020, FPC1021 and FPC1150) and sensor driver ...
(Date:8/18/2014)... native to a major Arizona watershed may lose access ... surface water flow is reduced by the effects of ... fish species, found in the Verde River Basin, are ... access to various resources throughout the river and its ... osculus), roundtail chub (Gila robusta) and Sonora sucker (Catostomus ...
(Date:8/18/2014)... Aarhus University, Denmark, and the University of Wisconsin-Madison, USA, have ... species to both climate and land use change. This new ... the face of combined rates of climate and land use ... results, which have just been published in Nature Climate ... losses in biodiversity and ecosystem function due to the individual ...
Breaking Biology News(10 mins):Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 2Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 3Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 4Climate change will threaten fish by drying out Southwest US streams, study predicts 2Climate change will threaten fish by drying out Southwest US streams, study predicts 3The double threat of climate and land use change enhances risks to biodiversity 2
... Few events involving animals are more dramatic than when ... cross-country. Among examples are the many thousands of wildebeests ... across the African plains. , Countless millions of ... with their own kind and form teeming, hungry islands ...
... components of our blood, are ancient proteins with well-known ... are also present in plants and bacteria, but until ... unclear. A group of researchers reveal this week that ... the fixation of nitrogen in the root nodules of ...
... Scientists at the U.S. Department of Energy's Brookhaven National ... in medical imaging to track the distribution of nutrients ... attack. The research provides new insights on a long-debated ... shows that radiotracer imaging can be a big help ...
Cached Biology News:Experiments provide proof of how traveling in groups protects insects 2Plant hemoglobins: Oxygen handlers critical for nitrogen fixation 2Poplar trees redirect resources in response to simulated attack 2Poplar trees redirect resources in response to simulated attack 3
... Vitro Transcription Kits synthesize RNA probes with ... cpm/g. High specific activity, single-stranded RNA ... in situ hybridization, and blot hybridizations. MAXIscript ... synthesis of modest amounts of unlabeled RNA ...
RAB32, member RAS oncogene family, mRNA (cDNA clone MGC:13500 IMAGE:4280407), complete cds...
Request Info...
Phospho-TAO2 (S181) Affinity Purified Polyclonal Ab Protein Family: Other Intracellular Kinases...
Biology Products: